pyrazines has been researched along with oxidopamine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Richardson, PJ; Sirinathsinghji, DJ; Vellucci, SV | 1 |
| Baldessarini, RJ; Tarazi, FI; Zhang, K | 1 |
| Chang, H; Conlon, PR; Engber, TM; Haque, S; Kiesman, WF; Kumaravel, G; Petter, RC; Sha, L; Wang, J; Whalley, ET; Yao, G | 1 |
| Jing, FC; Wang, DQ; Wang, W | 1 |
| Du, J; Duan, H; Guo, B; Lee, SM; Wang, Y; Xu, D; Zhang, Z | 1 |
| Guo, BJ; Han, YF; Hoi, PM; Lee, SM; Sun, YW; Wang, YQ; Xu, DP; Zhang, K; Zhang, ZJ | 1 |
| Chen, L; Cheng, L; Liu, H; Liu, X; Ren, Z; Wang, S; Wei, X; Wu, Y; Yuan, Z | 1 |
7 other study(ies) available for pyrazines and oxidopamine
| Article | Year |
|---|---|
Adenosine A2 receptor regulation of apomorphine-induced turning in rats with unilateral striatal dopamine denervation.
Topics: Acetylcholine; Adenosine; Animals; Antihypertensive Agents; Apomorphine; Atropine; Brain; Dopamine; Female; Naloxone; Neostriatum; Oxidopamine; Phenethylamines; Purinergic Antagonists; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrazines; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Sympathectomy, Chemical | 1993 |
Role of dopamine D(4) receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats.
Topics: Animals; Animals, Newborn; Autoradiography; Central Nervous System Stimulants; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Hyperkinesis; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Nerve Tissue Proteins; Oxidopamine; Pyrazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D4; Sympatholytics | 2001 |
Synthesis of alkyne derivatives of a novel triazolopyrazine as A(2A) adenosine receptor antagonists.
Topics: Adenosine A2 Receptor Antagonists; Administration, Oral; Alkynes; Animals; Catalepsy; Cerebral Cortex; Disease Models, Animal; Mice; Oxidopamine; Parkinson Disease; Pyrazines; Rats; Structure-Activity Relationship; Triazoles | 2005 |
[Effects of tetramethylpyrazine on brain oxidative damage induced by intracerebral perfusion of L-DOPA in rats with Parkinson's disease].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catechols; Chromatography, High Pressure Liquid; Corpus Striatum; Hydroxybenzoates; Levodopa; Male; Microdialysis; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Pyrazines; Random Allocation; Rats; Rats, Sprague-Dawley | 2007 |
Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antioxidants; Behavior, Animal; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Humans; Ligusticum; Male; Neuroprotective Agents; Nitrogen Oxides; Oxidative Stress; Oxidopamine; Parkinson Disease; Phytotherapy; Plant Extracts; Pyrazines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Substantia Nigra; Zebrafish | 2014 |
A novel tetramethylpyrazine bis-nitrone (TN-2) protects against 6-hydroxyldopamine-induced neurotoxicity via modulation of the NF-κB and the PKCα/PI3-K/Akt pathways.
Topics: Animals; Male; Neuroprotective Agents; NF-kappa B; Oxidopamine; PC12 Cells; Phosphatidylinositol 3-Kinases; Protein Kinase C-alpha; Proto-Oncogene Proteins c-akt; Pyrazines; Rats; Rats, Sprague-Dawley; Signal Transduction; Zebrafish | 2014 |
Tetramethylpyrazine Analogue CXC195 Protects Against Dopaminergic Neuronal Apoptosis via Activation of PI3K/Akt/GSK3β Signaling Pathway in 6-OHDA-Induced Parkinson's Disease Mice.
Topics: Animals; Apoptosis; Dopaminergic Neurons; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3 beta; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Phosphatidylinositol 3-Kinases; Piperazines; Proto-Oncogene Proteins c-akt; Pyrazines; Random Allocation; Signal Transduction | 2017 |